Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Jacobs syndrome 1 Gastrointestinal Neoplasms 1

Interventions

Specimen Handling 655 pembrolizumab 605 Magnetic Resonance Spectroscopy 562 Carboplatin 445 Cisplatin 396 Cyclophosphamide 394 Biopsy 378 Nivolumab 323 Paclitaxel 320 Gemcitabine 313 Radiotherapy 293 Bevacizumab 248 Dexamethasone 221 fludarabine 212 Docetaxel 201 durvalumab 193 atezolizumab 186 Oxaliplatin 186 venetoclax 182 Fluorouracil 175 Rituximab 173 Pemetrexed 172 Capecitabine 170 Radiation 166 Doxorubicin 166 Radiosurgery 158 Ipilimumab 145 Etoposide 142 Leucovorin 140 Lenalidomide 137

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

avatrombopag × 90 days × Clear all

NCT05772546 2026-03-13

ACT-GI

Massachusetts General Hospital

Phase 2 Active not recruiting

Gastrointestinal

Jacobs syndrome, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡